Anemia, Diabetes, Kidney Disease, Chronic, Hypertension Clinical Trial
Official title:
Prevalence of Anaemia Secondary to Early Stage Chronic Kidney Disease in High Risk Diabetic and/or Hypertensive Population
| Verified date | March 2018 |
| Source | Hoffmann-La Roche |
| Contact | n/a |
| Is FDA regulated | No |
| Health authority | |
| Study type | Observational |
The purpose of this study is to evaluate the prevalence of CKD-related anemia at an early stage through screening of high-risk patients in Pakistan at the level of physicians, cardiologists, and diabetologists. The information gathered may serve as a foundation in formulating national guidelines for better early diagnosis and management of patients with CKD.
| Status | Completed |
| Enrollment | 246 |
| Est. completion date | August 2012 |
| Est. primary completion date | August 2012 |
| Accepts healthy volunteers | No |
| Gender | All |
| Age group | 40 Years and older |
| Eligibility |
Inclusion Criteria: - Age greater than or equal to 40 years - Known hypertension and/or diabetes for at least 3 years - Positive dipstick test result for proteinuria Exclusion Criteria: - Known CKD - Receiving erythropoietin - Blood transfusion within 8 weeks - History of acute or chronic bleeding, hemolysis, or hemoglobinopathy |
| Country | Name | City | State |
|---|---|---|---|
| n/a | |||
| Lead Sponsor | Collaborator |
|---|---|
| Hoffmann-La Roche |
Pakistan,
| Type | Measure | Description | Time frame | Safety issue |
|---|---|---|---|---|
| Primary | Number of patients with anemia secondary to CKD | Up to 12 months | ||
| Secondary | Use of treatment modalities for the management of anemia secondary to CKD | Up to 12 months |